Company Overview

Company name: Vitality Biopharma (GREY: VBIO)
Also known as:
Description: Distributor of medical cannabis. The company’s medical cannabis distribution business include importing, exporting and supplying of narcotic drugs for medical purposes in USA, enabling physicians to treat serious neurological and inflammatory conditions.
Year founded: 2007
Parent company:
Industry: Healthcare | Group: Pharmaceuticals and Biotechnology | Code:
Website: www.vitality.bio
Employees: 7
City: Los Angeles
State: California
Country: United States
Region: Americas

Financial Highlights

Start up capital raised (USD Million): 11.50
Business status: Profitable
Ownership: Publicly Held
Exchange: GREY
Ticker: VBIO
Revenue (USD Million): 0.11
Gross profit (USD Million): 0.03
Net income (USD Million) -4.66
Enterprise value: 51.69
Earnings before interest, tax, depreciation and amortization (EBITDA): -4.66
Fiscal period: TTM 2Q2019
Financing Status: The company (OTC: VBIO) received $8.5 million of development capital from an undisclosed investor on October 22, 2018 through a private placement. Proceeds from the company’s financing will support drug development operations as well as the commencement of operations for a wholly-owned subsidiary, Vitality Healthtech.
Number of active investors:
Profile last updated: 11-Nov-2018
Last known valuation:
Last known valuation date: